Compare RNXT & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNXT | MBBC |
|---|---|---|
| Founded | 2012 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.4M | 44.1M |
| IPO Year | 2021 | 2020 |
| Metric | RNXT | MBBC |
|---|---|---|
| Price | $2.38 | $15.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.25 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 2.0K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.00 | ★ 122.22 |
| EPS | N/A | ★ 0.53 |
| Revenue | ★ $1,123,000.00 | N/A |
| Revenue This Year | $194.66 | N/A |
| Revenue Next Year | $279.78 | N/A |
| P/E Ratio | ★ N/A | $28.53 |
| Revenue Growth | ★ 2511.63 | N/A |
| 52 Week Low | $0.70 | $10.25 |
| 52 Week High | $2.59 | $15.79 |
| Indicator | RNXT | MBBC |
|---|---|---|
| Relative Strength Index (RSI) | 74.96 | 51.62 |
| Support Level | $0.83 | $14.63 |
| Resistance Level | N/A | $15.41 |
| Average True Range (ATR) | 0.25 | 0.15 |
| MACD | 0.11 | 0.00 |
| Stochastic Oscillator | 78.91 | 71.76 |
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.